These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 25453585
1. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Merz M, Kroll R, Lynen R, Bangerter K. Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585 [Abstract] [Full Text] [Related]
2. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Gruber D, Skřivánek A, Serrani M, Lanius V, Merz M. Contraception; 2015 Feb; 91(2):105-12. PubMed ID: 25453582 [Abstract] [Full Text] [Related]
3. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen. Weisberg E, Merki-Feld GS, McGeechan K, Fraser IS. Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098 [Abstract] [Full Text] [Related]
5. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study. Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T. Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778 [Abstract] [Full Text] [Related]
6. Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study. Wiegratz I, Bassol S, Weisberg E, Mellinger U, Merz M. Reprod Sci; 2014 Dec; 21(12):1518-25. PubMed ID: 24784719 [Abstract] [Full Text] [Related]
9. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive. Portman DJ, Kaunitz AM, Howard B, Weiss H, Hsieh J, Ricciotti N. Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794 [Abstract] [Full Text] [Related]
10. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S. Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587 [Abstract] [Full Text] [Related]
16. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Contraception; 1987 Mar 30; 35(3):199-205. PubMed ID: 2956054 [Abstract] [Full Text] [Related]
17. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles. Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K. Contraception; 1997 Nov 30; 56(5):285-90. PubMed ID: 9437556 [Abstract] [Full Text] [Related]
18. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women. Kaunitz AM, Archer DF, Mishell DR, Foegh M. Am J Obstet Gynecol; 2015 Mar 30; 212(3):318.e1-8. PubMed ID: 25220709 [Abstract] [Full Text] [Related]
19. An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch. Zhang C, Li H, Xiong X, Zhai S, Wei Y, Zhang S, Zhang Y, Xu L, Liu L. Drug Des Devel Ther; 2017 Mar 30; 11():725-731. PubMed ID: 28331292 [Abstract] [Full Text] [Related]